PRTN3 and rheumatoid arthritis: Citrullinated proteins present in the synovial fluid of RA patients are thus a known hallmark of the disease, and these modified proteins are thought to lead to the production of anti-citrulline peptide antibodies (ACPA) that intensify the auto-immune and inflammatory response experienced by patients [23,24].